Intrahospital management of women with preeclampsia;Principes généraux de la prise en charge hospitalière de la prééclampsie

Annales Francaises d'Anesthesie et de Reanimation

Volumn 29, Issue 4, 2010, Pages

  Diemunsch, P ^a   Langer, B ^a   Noll, E ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

Antihypertensive agents; Eclampsia; Hypertension; Obstetrics; Preeclampsia

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAMETHASONE; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; CORTICOSTEROID; DEXAMETHASONE; DEXAMETHASONE SODIUM PHOSPHATE; DIHYDRALAZINE; DIHYDROPYRIDINE DERIVATIVE; HYDRALAZINE; LABETALOL; MAGNESIUM SULFATE; METHYLDOPA; METOPROLOL; NICARDIPINE; NIFEDIPINE; PINDOLOL;

AMENORRHEA; ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; FEMALE; FETUS MONITORING; GESTATION PERIOD; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPOTENSION; MEDICAL ASSESSMENT; MONITORING; MOTHER; MUSCLE WEAKNESS; PREECLAMPSIA;

ADRENAL CORTEX HORMONES; ADULT; ANTI-INFLAMMATORY AGENTS; ANTIHYPERTENSIVE AGENTS; FEMALE; FETAL MONITORING; HOSPITALIZATION; HUMANS; MAGNESIUM COMPOUNDS; MONITORING, PHYSIOLOGIC; NICARDIPINE; PRE-ECLAMPSIA; PREGNANCY;

EID: 77952881750     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2010.02.018     Document Type: Article

References (68)

1. Winer N., Branger Prise en charge de la prééclampsie dans un réseau de périnatalité. Ann Fr Anesth Réanim 2010, 29:e47-e50.
2. Goldenberg R.L., Cliver S.P., Bronstein J., Cutter G.R., Andrews W.W., Mennemeyer S.T. Bed rest in pregnancy. Obstet Gynecol 1994, 84:131-136.
3. Helewa M., Heaman M., Robinson M.A., Thompson L. Community-based home-care program for the management of pre-eclampsia: an alternative. CMAJ 1993, 149:829-834.
4. Odendaal H.J., Pattinson R.C., Bam R., Grove D., Kotze T.J. Aggressive or expectant management for patients with severe preeclampsia between 28-34 weeks'gestation: A randomized controlled trial. Obstet Gynecol 1990, 76:1070-1075.
5. Sibai B.M., Mercer B.M., Schiff E., Friedman S.A. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks'gestation: a randomized controlled trial. Am J Obstet Gynecol 1994, 171:818-822.
6. Chua S., Redman C.W. Prognosis for preeclampsia complicated by 5g or more of proteinuria in 24hours. Eur J Obstet Gynecol Reprod Biol 1992, 43:9-12.
7. Olah K.S., Redman W.G., Gee H. Management of severe, early pre-eclampsia: is conservative management justified?. Eur J Obstet Gynecol Reprod Biol 1993, 51:175-180.
8. Visser W., Wallenburg H.C.S. Maternal and perinatal outcome of temporizing management in 254 consecutive patients with severe preeclampsia remote from term. Eur J Obstet Gynecol Reprod Biol 1995, 63:147-154.
9. Chammas M.F., Nguyen T.M., Li M.A., Nuwayhid B.S., Castro L.C. Expectant management of severe preterm preeclampsia: Is intrauterine growth restriction an indication for immediate delivery?. J Obstet Gynecol 2000, 183:853-858.
10. Hall D.R., Odendaal H.J., Steyn D.W., Grove D. Expectant management of early onset, severe preeclampsia; maternal outcome. BJOG 2000, 107:1252-1257.
11. Hall D.R., Odendaal H.J., Kristen G.F., Smith J., Grove D. Expectant management of early onset, severe preeclampsia: perinatal outcome. BJOG 2000, 107:1258-1264.
12. Vigil-DeGarcia P., Montufar-Rueda C., Ruiz J. Expectant management of severe preeclampsia between 24 and 34 weeks'gestation. Eur J Obstet Gynecol Reprod Biol 2003, 107:24-27.
13. Haddad B., Deis S., Goffinet F., Daniel B.J., Cabrol D., Sibai B.M. Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks'gestation. Am J Obstet Gynecol 2004, 190:1590-1595.
14. Shear R.M., Rinfret D., Leduc L. Should we offer expectant management in cases of severe preterm preeclampsia with fetal growth restriction?. Am J Obstet Gynecol 2005, 192:1119-1125.
15. Oettle C., Hall D., Roux A., Grove D. Early onset severe preeclampsia: expectant management at a secondary hospital in close association with a tertiary institution. BJOG 2005, 112:84-88.
16. Ganzevoort W., Rep A., Bonsel G.J., Fetter W.P., van Sonderen L., De Vries J.I., et al. A randomized controlled trial comparing two temporizing management strategies, one with and one without plasma volume expansion, for severe and early onset pre-eclampsia. BJOG 2005, 112:1358-1368.
17. Girling J.C., Dow E., Smith J.H. Liver function tests in pre-eclampsia: importance of comparison with a reference range derived for normal pregnancy. Br J Obstet Gynaecol 1997, 104:246-250.
18. Poldre P.A. Haptoglobin helps diagnose the HELLP syndrome. Am J Obstet Gynecol 1987, 157:1267.
19. National high blood pressure education program working group Report on high blood pressure in pregnancy. Am J Obstet Gynecol 1990;163:1689-712.
20. Sibai B., Barton J.R. Expectant management of severe preeclampsia remote from term: patient selection, treatment, and delivery indications. Am J Obstet Gynecol 2007, 196. 514.e1-514.e9.
21. Bilardo C.M., Wolf H., Stigter R.H., Ville Y., Baez E., Visser G.H., et al. Relationship between monitoring parameters and perinatal outcome in severe, early intrauterine growth restriction. Ultrasound Obstet Gynecol 2004, 23:119-125.
22. Moodley J. Maternal deaths due to hypertensive disorders in pregnancy: Saving Mothers report 2002- 2004. Cardiovasc J Afr 2007, 18:358-361.
23. Khatun S., Kanayama N., Hossain B., el Maradny E., Kobayashi T., Jahan S., et al. Increased concentrations of plasma epinephrine and norepinephrine in patients with eclampsia. Eur J Obstet Gynecol Reprod Biol 1997, 74:103-109.
24. Olsen K.S., Beier-Holgersen R. Fetal death following labetalol administration in pre-eclampsia. Acta Obstet Gynecol Scand 1992, 7:145-147.
25. Magpie Trial Collaboration Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 2002;359:1877-90.
26. Katz V.L., Farmer R., Kuller J.A. Preeclampsia into eclampsia: toward a new paradigm. Am J Obstet Gynecol 2000, 182:1389-1396.
27. Schwartz R.B., Feske S.K., Polak J.F., De Girolami U., Iaia A., Beckmer K.M., et al. Preeclampsia-eclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy. Radiology 2000, 217:371-376.
28. Montan S., Ingermarsson I., Marsal K., Sjöberg N.O. Randomised controlled trial of atenolol and pindolol in human pregnancy: Effects on fetal haemodynamics. Br Med J 1992, 304:946-949.
29. Hjertberg R., Faxelius G., Lagercrantz H. Neonatal adaptation in hypertensive pregnancy-a study of labetalol vs hydralazine treatment. J Perinat Med 1993, 21:69-75.
30. Duley L., Henderson-Smart D.J., Meher S. Drugs for treatment of very high blood pressure during pregnancy (Review). Cochrane Database of Systematic Reviews 2006, 3:1-82.
31. Vaast P., Dubreucq-Fossaert S., Houfflin-Debarge V., Provost-Helou N., Ducloy-Bouthors A.S., Puech F., et al. Acute pulmonary oedema during nicardipine therapy for preterm labour; report of five cases. Eur J Obstet Gynecol Reprod Biol 2004, 113:98-99.
32. Impey L. Severe hypotension and fetal distress following sublingual administration of nifedipine to a patient with severe pregnancy induced hypertension at 33 weeks. Br J Obstet Gynecol 1993, 100:959-961.
33. Jannet D., Carbonne B., Sebban E., Milliez J. Nicardipine versus metoprolol in the treatment of hypertension during pregnancy: a randomized comparative trial. Obstet Gynecol 1994, 84:354-359.
34. Carbonne B., Jannet D., Touboul C., Khelifati Y., Milliez J. Nicardipine treatment of hypertension during pregnancy. Obstet Gynecol 1993, 81:908-914.
35. Aya A.G., Mangin R., Hoffet M., Eledjam J.J. Intravenous nicardipine for severe hypertension in pre-eclampsia-effects of an acute treatment on mother and foetus. Intensive Care Med 1999, 25:1277-1281.
36. Belfort M.A., Anthony J., Saade G.R., Allen J.C. Nimodipine Study Group. A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N Engl J Med 2003, 348:304-311.
37. Magee L.A., Ornstein M.P., von Dadelszen P. Fortnightly review: management of hypertension in pregnancy. BMJ 1999, 318:1332-1336.
38. Kwawukume E.Y., Ghosh T.S. Oral nifedipine therapy in the management of severe preeclampsia. Int J Gynaecol Obstet 1995, 49:265-269.
39. Horvath J.S., Phippard A., Korda A., Henderson-Smart D.J., Child A., Tiller D.J. Clonidine-hydrochloride - a safe and effective antihypertensive agent in pregnancy. Obstet Gynecol 1985, 66:634-638.
40. Boutroy M.J., Gisonna C.R., Legagneur M. Clonidine: placental transfer and neonatal adaptation. Early Hum Dev 1988, 17:275-286.
41. Dooley M., Goa K.L. Urapidil. A reappraisal of its use in the management of hypertension. Drugs 1998, 56:929-955.
42. Amorim M.M.R., Santos L.C., Faùndes A. Corticosteroid therapy for prevention of respiratory distress syndrome in severe preeclampsia. Am J Obstet Gynecol 1999, 180:1283-1288.
43. Baud O., Foix-L'Helias L., Kaminski M., Audibert F., Jarreau P.H., Papiernik E., et al. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med 1999, 341:1190-1196.
44. Ogunyemi D. Risk factors for acute pulmonary edema in preterm delivery. Eur J Obstet Gynecol Reprod Biol 2007, 133:143-147.
45. Dubé L., Granry J. The therapeutic use of magnesium in anesthesiology, intensive care and emergency medicine: a review. Can J Anesth 2003, 50:732-746.
46. Fawcett W., Haxby E., Male D. Magnesium: physiology and pharmacology. Br J Anaesth 1999, 83:302-320.
47. James M. Clinical Use of Magnesium Infusions in Anesthesia. Anesth Analg 1992, 74:129-136.
48. Shimosawa T., Takano K., Ando K., Fujita T. Magnesium inhibits norepinephrine release by blocking N-type calcium channels at peripheral sympathetic nerve endings. Hypertension 2004, 44:897-902.
49. Satake K., Lee J.D., Shimizu H., Uzui H., Mitsuke Y., Yue H., et al. Effects of magnesium on prostacyclin synthesis and intracellular free calcium concentration in vascular cells. Magnes Res 2004, 17:20-27.
50. Schauf B., Becker S., Abele H., Klever T., Wallwiener D., Aydeniz B. Effect of magnesium on red blood cell deformability in pregnancy. Hypertens Pregnancy 2005, 24:17-27.
51. Macones G., Hauth J.C., Lockwood C.J. Magnesium sulfate tocolysis: time to quit. Obstet Gynecol 2007, 109:450-451.
52. Grimes D.A., Nanda K. Magnesium sulfate tocolysis: time to quit. Obstet Gynecol 2006, 108:986-989.
53. Davis W.B., Wells S.R., Kuller J.A., Thorp J.M. Analysis of the risks associated with calcium channel blockade: implications for the obstetrician-gynecologist. Obstet Gynecol Surv 1997, 52:198-201.
54. Durand P., Lehot J.J., Foëx P. Calcium-channel blockers and anaesthesia. Can J Anesth 1991, 38:75-89.
55. Pittman J. Magnesium sulphate for pre-eclampsia and a sudden bradycardia. Br J Anaesth 2000, 85:327-328.
56. Thomas T., Cooper G. Maternal deaths from anaesthesia. An extract from Why Mothers Die 1997-1999, the Confidential Enquiries into Maternal Deaths in the United Kingdom. Br J Anaesth 2002, 89:499-508.
57. Scardo J.A., Vermillion S.T., Hogg B.B., Newman R.B. Hemodynamic effects of oral nifedipine in preeclamptic hypertensive emergencies. Am J Obstet Gynecol 1996, 175:336-338.
58. Magee L.A., Miremadi S., Li J., Cheng C., Ensom M.H., Carleton B., et al. Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia. Am J Obstet Gynecol 2005, 193:153-163.
59. Magpie Trial Follow-Up Study Collaborative Group. The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for women at 2 years. BJOG 2007;114:300-9.
60. Ravn H.B., Lassen J.F., Bergenhem N., Kristensen A.T. Intravenous magnesium does not influence the activity of the coagulation cascade. Blood Coagul Fibrinolysis 2001, 12:223-228.
61. Stewart D., Marder V.J., Starkman S., Saver J.L. Magnesium sulfate neither potentiates nor inhibits tissue plasminogen activator-induced thrombolysis. J Thromb Haemost 2006, 4:1575-1579.
62. Harnett M.J., Datta S., Bhavani-Shankar K. The effect of magnesium on coagulation in parturients with preeclampsia. Anesth Analg 2001, 92:1257-1260.
63. Réanimation des formes graves de prééclampsie. Conférence d'experts de la Sfar. Paris: Elsevier; 2000.
64. Duley L, Williams J, Henderson-Smart DJ. Plasma volume expansion for treatment of pre-eclampsia (Cochrane Review). In: The Cochrane Library, Issue 4, 2002. Oxford: Update Software.
65. Cotton D.B., Gonik B., Dorman K.F. Cardiovascular alterations in severe pregnancy-induced hypertension seen with an intravenously given hydralazine bolus. Surg Gynecol Obstet 1985, 161:240-244.
66. Recommandations pour la pratique clinique Sfar-SRLF. Remplissage vasculaire au cours des hypovolémies relatives ou absolues. Ann Fr Anesth Réanim 1997;16:8-14.
67. Haddad B., et al. Critères d'arrêt de la grossesse en cas de prééclampsie. Ann Fr Anesth Réanim 2010, 29:e59-e68.
68. Zupan-Simunek V. Pronostic des nouveau-nés de mère prééclamptique. Ann Fr Anesth Réanim 2010;29 (). doi:10.1016/j.annfar.2010.03.013.